Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials

Achieving Remission and Favorable Outcomes in Patients with Depression/Anxiety and Substance use Disorders

(2016) Alan F. Schatzberg   CNS SPECTRUMS

Inflammation, Glutamate, and Glia in Depression: A Literature Review

(2015) Leah McNally et al.   CNS SPECTRUMS

Augmentation of Aripiprazole for Depressed Patients With an Inadequate Response to Antidepressant Treatment

(2013) Duk-In Jon et al.   CLINICAL NEUROPHARMACOLOGY

Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence-Based Support from the Medical Literature

(2013) Bradley M. Wright et al.   PHARMACOTHERAPY

Mood disorders and complementary and alternative medicine: a literature review

(2013) Naseem Akhtar Qureshi et al.   Neuropsychiatric Disease and Treatment

Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder

(2012) Nayereh Khoraminya et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

(2012) Robert K McNamara et al.   Expert Review of Neurotherapeutics

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study

(2012) Seyed-Hesameddin Abbasi et al.   JOURNAL OF AFFECTIVE DISORDERS

The role of the innate immune system in psychiatric disorders

(2012) Kenneth A. Jones et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

PROINFLAMMATORY AND “RESILIENCY” PROTEINS IN THE CSF OF PATIENTS WITH MAJOR DEPRESSION

(2011) Jose M. Martinez et al.   DEPRESSION AND ANXIETY

Maintenance therapy of celecoxib for major depression with mimicking neuropsychological dysfunction

(2010) Chun-Yen Chen et al.   GENERAL HOSPITAL PSYCHIATRY

Inflammatory Biomarkers and Depression

(2010) Norbert Müller et al.   NEUROTOXICITY RESEARCH

Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

(2010) Norbert Müller et al.   SCHIZOPHRENIA RESEARCH

Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials

(2009) J. Craig Nelson et al.   AMERICAN JOURNAL OF PSYCHIATRY

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

(2009) Andrew H. Miller et al.   BIOLOGICAL PSYCHIATRY

A Meta-Analysis of Cytokines in Major Depression

(2009) Yekta Dowlati et al.   BIOLOGICAL PSYCHIATRY

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

(2009) Shahin Akhondzadeh et al.   DEPRESSION AND ANXIETY

Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain

(2009) Jian-You Guo et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Treating Depression to Full Remission

(2009) Madhukar H. Trivedi   JOURNAL OF CLINICAL PSYCHIATRY

Elevated Inflammation Levels in Depressed Adults With a History of Childhood Maltreatment

(2008) Andrea Danese et al.   ARCHIVES OF GENERAL PSYCHIATRY

Inflammatory markers in depression

(2008) Timothy G Dinan   CURRENT OPINION IN PSYCHIATRY

Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study

(2008) Fabiano G. Nery et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL